CARCINOID TUMOR

This French study is testing whether a combination of two immunotherapy drugs can help control five types of advanced rare cancers that have progressed after standard treatment. It will enroll 154 adults whose cancers have specific rare origins, such as certain mesotheliomas, thy…

This study is testing a more flexible way to give the cancer drug cabozantinib to people with advanced kidney cancer or neuroendocrine tumors. The goal is to see if adjusting the dose up or down based on how patients feel can help them stay on treatment longer with fewer severe s…

This study is testing whether a new radioactive drug called RYZ101 works better than standard treatments for advanced neuroendocrine tumors of the gut and pancreas. It's for people whose tumors have grown despite previous radiation therapy. The trial will measure how long the dru…

This study is testing whether virtual reality (VR) can help reduce pain and improve quality of life for people with gastrointestinal cancers. Researchers will compare three approaches: VR that teaches pain management skills, VR designed to distract from pain, and a basic VR contr…

This study is testing whether an investigational drug called paltusotine can better control the main symptoms of carcinoid syndrome—flushing and diarrhea—compared to a placebo. It will involve about 141 adults who have carcinoid syndrome due to neuroendocrine tumors. Participants…

This study aims to create a detailed national picture of lung cancer in Algeria by observing patients in their normal care. It will track about 3,750 adults with lung cancer across 21 hospitals to understand their diagnosis, treatments, and health outcomes. The goal is to gather …